The Effect of Rho-Kinase Inhibitors on In-Vitro Human Orbital Preadipocytes

被引:0
|
作者
Horacek, Meredith [1 ]
Yoo, David [1 ]
Yoon, Jin [2 ]
Bu, Ping [1 ]
Chae, Min [2 ]
Kim, Ji [2 ]
机构
[1] Loyola Univ Hlth Syst, Ophthalmol, Maywood, IL USA
[2] Yonsei Univ Hlth Syst, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
4055
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Editorial: Rho-kinase inhibitors: Potential therapeutics for benign prostate hyperplasia
    Adam, R
    JOURNAL OF UROLOGY, 2003, 170 (06): : 2523 - 2524
  • [42] Rho-Kinase Inhibitors Targeted To The Pulmonary Vasculature For Treatment Of Pulmonary Hypertension
    Morena, D. T.
    Hanson, S.
    Terry, M.
    Blood, A.
    Wilson, S.
    Giri, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [43] Dual effects of Rho-kinase inhibitors on a rat model of inflammatory pain
    Paiva-Lima, Patricia
    Bakhle, Y. S.
    Francischi, Janetti N.
    PAIN RESEARCH & MANAGEMENT, 2014, 19 (06): : E172 - E178
  • [44] Expression Profile of Rho/Rho-Kinase in Human Glaucoma and Normal Ocular Tissues
    Goldhagen, B.
    Rao, V.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 : S59 - S59
  • [45] MEDI 376-Dihydropyrimidines are potent and selective Rho-kinase inhibitors
    Wang, Gren Z.
    Viet, Andrew
    Goodman, Krista
    Dowdell, Sarah
    Schon, Clark
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [46] Blood pressure-independent effects of Rho-kinase inhibitors in the kidney?
    Danser, AHJ
    JOURNAL OF HYPERTENSION, 2004, 22 (09) : 1675 - 1677
  • [47] Rho-kinase inhibitors:: Pharmacomodulations on the lead compound Y-32885
    Logé, C
    Wallez, V
    Scalbert, E
    Cario-Tourmaniantz, C
    Loirand, G
    Pacaud, P
    Lesieur, D
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2002, 17 (06) : 381 - 390
  • [48] Improving outcomes in retinal detachment: the potential role of rho-kinase inhibitors
    Halasz, Eva
    Townes-Anderson, Ellen
    Zarbin, Marco A.
    CURRENT OPINION IN OPHTHALMOLOGY, 2020, 31 (03) : 192 - 198
  • [49] Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity
    Hahmann, C.
    Schroeter, T.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (02) : 171 - 177
  • [50] Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity
    C. Hahmann
    T. Schroeter
    Cellular and Molecular Life Sciences, 2010, 67 : 171 - 177